Bio-Rad Laboratories, Inc. (BIO) Social Stream
Bio-Rad Laboratories Inc (BIO) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Bio-Rad Laboratories Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 29 weeks, BIO's average price target has gone up $10.6.
BIO reports an average of 18.44% for its upside potential over the past 47 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
BIO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 31 weeks, BIO's average broker recommendation rating improved by 0.4.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- BIO has a higher average analyst price target than 298.03% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the large market cap category, Bio-Rad Laboratories Inc's number of analysts covering the stock is greater than 5.1% of them.
- In terms of how Bio-Rad Laboratories Inc fares relative to stocks in the large market cap category, note that its variance in analysts' estimates is lower than 52.75% of that group.
- In the context of stocks in the large market cap category, Bio-Rad Laboratories Inc's upside potential (average analyst target price relative to current price) is higher than 230.4% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Measuring and Control Equipment industry with the ratings most similar to Bio-Rad Laboratories Inc are AVTR, A, and KLAC.
Is BIO a Buy, Hold or Sell? See the POWR Ratings now!